Analyst firms · TD Cowen · CTKB

TD Cowen CTKB price target and rating history

Cytek Biosciences Inc. (CTKB) · Health Care

TD Cowen rates Cytek Biosciences Inc. (CTKB) Hold with a $4 price target, as of its latest action on May 9, 2025. It has published 3 rating actions on CTKB since August 2021, including 0 upgrades and 1 downgrade.

Current rating
Hold
Price target
$4
Median target, all firms
Too few
Actions on CTKB
3

Every TD Cowen rating on CTKB

Questions about TD Cowen and CTKB

What is TD Cowen's price target for CTKB?
TD Cowen's latest stated price target for Cytek Biosciences Inc. (CTKB) is $4, from its action on May 9, 2025.
What is TD Cowen's rating on CTKB?
TD Cowen rates CTKB Hold, a neutral rating, as of May 9, 2025.
When did TD Cowen last change its view on CTKB?
On May 9, 2025, TD Cowen downgrades to Hold from Buy, price target $4.

More CTKB rating histories

All TD Cowen ratingsCTKB news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.